tradingkey.logo
tradingkey.logo
Search

Voyager Therapeutics Inc

VYGR
Add to Watchlist
3.100USD
+0.010+0.32%
Close 07-24 16:00ETQuotes delayed by 15 min
171.15MMarket Cap
LossP/E TTM

VYGR Financials

See Voyager Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Voyager Therapeutics Inc Earnings Date

Latest Release
May 7, 2026
EPS / Forecast
-0.47/-0.55
Revenue / Forecast
2.59M/8.78M
Period
FY2025 Earnings
Revenue(YoY)
40.37M
-49.53%
EPS(YoY)
-2.04
-80.97%
Analyst Rating
STRONG BUY
2026/07/25
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
11.68%-0.47
21.77%-0.47
-203.42%-0.47
-223.87%-0.57
-168.02%-0.53
-151.89%-0.59
73.52%-0.16
65.57%-0.18
-106.50%-0.20
--1.15
---0.59
---0.51
--3.05
----
---0.59
----
----
----
----
----
Revenue
-59.94%2.59M
144.28%15.34M
-45.73%13.37M
-82.42%5.20M
-66.83%6.47M
-93.03%6.28M
433.79%24.63M
509.48%29.58M
-87.03%19.52M
5710.39%90.06M
-88.77%4.61M
581.60%4.85M
22769.30%150.48M
-94.48%1.55M
2672.33%41.09M
-47.53%712.00K
-89.88%658.00K
329.45%28.07M
-98.74%1.48M
-95.27%1.36M
Net Profit
9.94%-27.94M
20.47%-27.43M
-208.40%-27.89M
-229.18%-33.38M
-173.80%-31.02M
-161.15%-34.49M
65.08%-9.04M
54.34%-10.14M
-109.13%-11.33M
338.70%56.40M
-246.96%-25.90M
-16.35%-22.21M
681.85%124.04M
-513.84%-23.63M
170.11%17.62M
36.63%-19.09M
1.52%-21.32M
135.85%5.71M
-129.36%-25.14M
-246.96%-30.12M
Net Margin
-124.82%-1077.40%
67.45%-178.83%
-468.33%-208.69%
-1772.39%-641.96%
-725.49%-479.24%
-977.26%-549.33%
93.46%-36.72%
92.51%-34.29%
-170.43%-58.05%
104.11%62.62%
---561.36%
---457.61%
--82.43%
---1524.26%
---53.66%
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
--100.00%
----
----
----
----
----
Revenue
-59.94%2.59M
144.28%15.34M
-45.73%13.37M
-82.42%5.20M
-66.83%6.47M
-93.03%6.28M
433.79%24.63M
509.48%29.58M
-87.03%19.52M
5710.39%90.06M
-88.77%4.61M
581.60%4.85M
22769.30%150.48M
-94.48%1.55M
2672.33%41.09M
-47.53%712.00K
-89.88%658.00K
329.45%28.07M
-98.74%1.48M
-95.27%1.36M
Operating profit
12.75%-30.27M
21.85%-29.93M
-122.02%-30.59M
-199.59%-36.63M
-114.38%-34.69M
-170.84%-38.30M
53.30%-13.78M
51.92%-12.22M
-113.17%-16.18M
351.89%54.06M
-304.31%-29.51M
-31.29%-25.43M
675.57%122.88M
-476.41%-21.46M
157.43%14.44M
32.25%-19.37M
16.57%-21.35M
124.03%5.70M
-129.75%-25.15M
-218.28%-28.59M
Net Profit
9.94%-27.94M
20.47%-27.43M
-208.40%-27.89M
-229.18%-33.38M
-173.80%-31.02M
-161.15%-34.49M
65.08%-9.04M
54.34%-10.14M
-109.13%-11.33M
338.70%56.40M
-246.96%-25.90M
-16.35%-22.21M
681.85%124.04M
-513.84%-23.63M
170.11%17.62M
36.63%-19.09M
1.52%-21.32M
135.85%5.71M
-129.36%-25.14M
-246.96%-30.12M
Current assets
-40.06%146.98M
-26.78%202.69M
-41.20%219.59M
-40.28%227.89M
-40.07%245.21M
-13.41%276.81M
42.58%373.44M
35.22%381.57M
35.20%409.14M
156.78%319.68M
78.25%261.93M
86.10%282.18M
77.34%302.63M
-8.92%124.50M
16.43%146.94M
2.00%151.63M
-2.95%170.65M
-30.88%136.70M
-41.66%126.20M
-39.73%148.65M
Total current liabilities
-56.60%17.45M
-46.69%26.54M
-19.71%35.49M
4.62%41.98M
-44.58%40.21M
-22.82%49.79M
-28.33%44.21M
-11.60%40.13M
263.87%72.55M
-11.13%64.51M
-15.78%61.69M
-53.64%45.40M
-80.39%19.94M
42.39%72.59M
174.30%73.24M
296.68%97.93M
310.80%101.68M
90.47%50.98M
-36.50%26.70M
-63.44%24.69M
Total assets
-37.91%219.32M
-35.81%252.28M
-32.33%288.31M
-26.16%322.10M
-24.78%353.24M
11.89%393.05M
44.59%426.04M
38.25%436.23M
39.64%469.59M
120.44%351.28M
61.47%294.65M
67.30%315.54M
50.01%336.29M
-17.80%159.36M
-1.24%182.48M
-9.64%188.60M
-5.69%224.18M
-25.89%193.85M
-31.50%184.77M
-29.83%208.73M
Total liabilities
-43.31%45.66M
-39.76%56.20M
-28.46%68.49M
-22.47%78.16M
-37.42%80.54M
-18.85%93.29M
-19.17%95.73M
-13.48%100.81M
7.85%128.71M
14.58%114.96M
15.37%118.43M
-9.37%116.51M
-19.51%119.33M
1.55%100.34M
5.45%102.66M
30.92%128.55M
46.05%148.25M
-7.89%98.80M
-5.96%97.35M
-55.48%98.19M
Total equity
-36.32%173.67M
-34.59%196.08M
-33.45%219.82M
-27.27%243.94M
-20.00%272.70M
26.84%299.76M
87.44%330.31M
68.53%335.42M
57.12%340.89M
300.41%236.32M
120.76%176.22M
231.42%199.03M
185.73%216.96M
-37.91%59.02M
-8.69%79.82M
-45.67%60.05M
-44.25%75.93M
-38.40%95.06M
-47.41%87.42M
43.77%110.54M
Net operating income
11.81%-33.42M
-108.29%-30.26M
-11.01%-31.05M
-5.32%-33.26M
-164.48%-37.90M
38.85%-14.53M
-32.86%-27.97M
-3682.04%-31.58M
-52.44%58.77M
-94.05%-23.76M
-29.90%-21.05M
95.48%-835.00K
258.93%123.56M
-209.37%-12.24M
21.74%-16.21M
18.63%-18.48M
261.67%34.43M
150.94%11.20M
16.29%-20.71M
-7.15%-22.72M
Net investment
-80.34%8.10M
274.33%47.42M
-45.79%34.89M
105.38%1.93M
142.89%41.20M
-201.38%-27.20M
140.65%64.35M
-45.74%-35.94M
-762.93%-96.06M
90.75%26.83M
-555.92%-158.30M
31.74%-24.66M
172.46%14.49M
357.45%14.07M
142.13%34.72M
-261.26%-36.13M
-157.76%-20.00M
74.60%-5.46M
-47.58%14.34M
1318.99%22.41M
Net financing
3963.41%3.33M
-76.31%136.00K
507.14%85.00K
-10.16%513.00K
-99.93%82.00K
24.78%574.00K
-95.77%14.00K
-63.11%571.00K
260.49%112.86M
66.67%460.00K
2106.67%331.00K
91.82%1.55M
260783.33%31.31M
21.59%276.00K
--15.00K
126.05%807.00K
-57.14%12.00K
-53.29%227.00K
-100.00%0.00
-83.26%357.00K

FAQs

What is the total revenue of Voyager Therapeutics Inc?

According to Voyager Therapeutics Inc's FY2025 earnings report, its total revenue reached 40.37M, with a year-on-year change of 80.00M.

What are the current assets of Voyager Therapeutics Inc?

According to Voyager Therapeutics Inc's FY2025 earnings report, its current assets were 202.69M, with a year-on-year change of -26.78.

What are the total assets of Voyager Therapeutics Inc?

According to Voyager Therapeutics Inc's FY2025 earnings report, its total assets of Voyager Therapeutics Inc were 252.28M, with a year-on-year change of -35.81.

What are the total liabilities of Voyager Therapeutics Inc?

According to Voyager Therapeutics Inc's FY2025 earnings report, its total liabilities of Voyager Therapeutics Inc were 56.20M, with a year-on-year change of -39.76.

What is the total equity of Voyager Therapeutics Inc?

According to Voyager Therapeutics Inc's FY2025 earnings report, its total equity of Voyager Therapeutics Inc was 196.08M, with a year-on-year change of -34.59.

What is the net operating income of Voyager Therapeutics Inc?

According to Voyager Therapeutics Inc's FY2025 earnings report, its net operating income of Voyager Therapeutics Inc was -131.84M, with a year-on-year change of -63.81.

What is the net investment of Voyager Therapeutics Inc?

According to Voyager Therapeutics Inc's FY2025 earnings report, its net investment of Voyager Therapeutics Inc was 125.45M, with a year-on-year change of 232.24.

What is the net financing of Voyager Therapeutics Inc?

According to Voyager Therapeutics Inc's FY2025 earnings report, its net financing of Voyager Therapeutics Inc was 816.00K, with a year-on-year change of -99.28.

What is the Earnings Per Share (EPS) of Voyager Therapeutics Inc?

According to Voyager Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.04, with a year-on-year change of -80.97.

What is the net income of Voyager Therapeutics Inc?

According to Voyager Therapeutics Inc's FY2025 earnings report, its net income was -119.72M, with a year-on-year change of -84.18.

What is the net margin of Voyager Therapeutics Inc?

According to Voyager Therapeutics Inc's FY2025 earnings report, its net profit margin was -296.53, with a year-on-year change of -264.95.

What is the Return on Equity (ROE) of Voyager Therapeutics Inc?

According to Voyager Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -48.29, with a year-on-year change of -99.13.

What is the Return on Assets (ROA) of Voyager Therapeutics Inc?

According to Voyager Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -37.10, with a year-on-year change of -112.44.

What is the operating profit of Voyager Therapeutics Inc?

According to Voyager Therapeutics Inc's FY2025 earnings report, its operating profit was -131.84M, with a year-on-year change of -63.81.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.